lenvatinib,sunitinib,everolimus,pembrolizumab
merck,pfizer,eisai
['clear trial']
dr. presented updated results of clear trial with 4y fu. overall the benefit is maintained overtime. attention to the high censoring in the end of the curves. #asco23 
Medical oncologist at @BPorgbr. Former fellow of GU oncology @DanaFarber @Harvard @MOCbrasil. #GUcancer